<?xml version="1.0" encoding="UTF-8"?>
<p>The cardinal symptoms of COVID-19 are cough, fever, and shortness of breath. These symptoms appear 2â€“14 days after infection (
 <xref rid="B4" ref-type="bibr">4</xref>, 
 <xref rid="B5" ref-type="bibr">5</xref>). The clinical picture varies from pausymptomatic to more serious clinical situations such as severe respiratory failure, sepsis, shock, and multiple organ dysfunction syndrome (
 <xref rid="B6" ref-type="bibr">6</xref>). Currently, there is no specific treatment for COVID-19, so drugs need to be developed or reused to end the pandemic. The World Health Organization has launched a clinical trial called SOLIDARITY to investigate 4 potential treatments: lopinavir and ritonavir plus interferon-beta, lopinavir and ritonavir, chloroquine/hydroxychloroquine, and remdesivir (
 <xref rid="B7" ref-type="bibr">7</xref>). The medical profession has quickly realized that there is no cure for this disease and vaccines will not be available for several months. This leaves a large unmet need for safe and effective treatments for COVID-19-infected patients. Obviously, there is a very urgent need for a cheap, viable, and readily available treatment such as melatonin (
 <xref rid="B8" ref-type="bibr">8</xref>).
</p>
